Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedMinor version update from v3.3.1 to v3.3.2 with no visible changes to study content.SummaryDifference0.0%

- Check13 days agoChange DetectedA new note states that publications are automatically filled from PubMed and may or may not be about the study. The page revision was updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check20 days agoChange DetectedA new study location, Tainan, Taiwan, 704, was added and the existing Tainan City, Taiwan, 704 was removed. A notice about lapse in government funding related to site operations was deleted.SummaryDifference0.2%

- Check35 days agoChange DetectedNo additions or deletions were detected; the page content remains unchanged.SummaryDifference0.2%

- Check63 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check71 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.